Osprey Medical
  • DyeVert™
    • DyeVert™ PLUS EZ
    • Instructions for Use – United States Only
  • Be Kind to Kidneys™
  • Patients
    • About Your Kidneys
    • Patients at Risk
    • Kidney Kindness in the Cath Lab
    • Martha’s Story
    • DyeVert™ Plus System
  • International
    • DyeVert™ PLUS EZ
    • DyeVert™ Power XT
    • Instructions for Use – International
    • Instructions for Use – Australia
    • Instructions for Use – Canada
  • About Us
    • Management
    • Board of Directors
    • Patents
    • Contact Us
  • Search
  • Menu Menu

Archive for category: News

EuroPCR 2016

DyeVert Pilot Trial Results Presented at EuroPCR

May 20, 2016/in News

Osprey Medical Inc. is pleased to announce the results of the DyeVert Pilot Trial as presented at the European Association of Percutaneous Cardiovascular Intervention’s annual conference (EuroPCR) during May 19th in Paris, France. The results from the clinical trial were presented to one of the world’s largest international conferences in the area of cardiovascular medicine with over 12,000 attendees.

Professor Steffen Desch presented the results of the DyeVert pilot trial that was performed at the Heart Centre in Lübeck, Germany and Monash Medical Centre in Melbourne, Australia. Monash’s Dr. James Sapontis was the principal investigator of the study. This prospective, non-randomized, single arm trial found that the DyeVert™ System saved 47.4% contrast dye on average in all patients, 50.3% in PCI/Stenting and 46.6% in diagnostic procedures.

Read more

https://ospreymed.com/wp-content/uploads/2017/05/europcr.jpg 235 280 Rob Coleman https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Rob Coleman2016-05-20 01:07:042017-07-05 20:19:55DyeVert Pilot Trial Results Presented at EuroPCR
Page 2 of 212

Osprey Medical Events

NCDR 2019 Annual Conference
March 13-15, 2019
New Orleans, LA

ACC.19
March 16-18, 2019
New Orleans, LA

SCAI Conference
May 19-22, 2019
Las Vegas, NV

TCT 2019
September 25-29, 2019
San Francisco, CA

Recent Posts

  • Osprey receives Supplier Horizon Award from Premier Inc
  • GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)
  • US Government to Transform Kidney Care
  • AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference
  • Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System

Archives

  • September 2020
  • July 2020
  • July 2019
  • June 2019
  • December 2018
  • September 2018
  • June 2017
  • March 2017
  • November 2016
  • October 2016
  • May 2016

© 2022 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.

Osprey YouTubeOsprey TwitterOsprey Facebook

Contact     Resources     Privacy     Terms of Use

Contact     Resources     Privacy     Terms of Use

Scroll to top

Analyst Coverage Disclaimer Please note that any opinions, esimates or forecasts regarding Osprey Medical's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Osprey Medical or its management. Osprey Medical does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Osprey Medical cannot guarantee its accuracy.

Check if you have read and acknowledged.